The ADMA-Metformin Hypothesis: Linking the Cardiovascular Consequences of the Metabolic Syndrome and Type 2 Diabetes
about
Improved Muscle Function in Duchenne Muscular Dystrophy through L-Arginine and Metformin: An Investigator-Initiated, Open-Label, Single-Center, Proof-Of-Concept-Study.Asymmetric dimethylarginine attenuates serum starvation-induced apoptosis via suppression of the Fas (APO-1/CD95)/JNK (SAPK) pathway.Prenatal Metformin Therapy Attenuates Hypertension of Developmental Origin in Male Adult Offspring Exposed to Maternal High-Fructose and Post-Weaning High-Fat Diets.Differential associations of circulating asymmetric dimethylarginine and cell adhesion molecules with metformin use in patients with type 2 diabetes mellitus and stable coronary artery disease.
P2860
The ADMA-Metformin Hypothesis: Linking the Cardiovascular Consequences of the Metabolic Syndrome and Type 2 Diabetes
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
The ADMA-Metformin Hypothesis: ...... c Syndrome and Type 2 Diabetes
@en
The ADMA-Metformin Hypothesis: ...... Syndrome and Type 2 Diabetes.
@nl
type
label
The ADMA-Metformin Hypothesis: ...... c Syndrome and Type 2 Diabetes
@en
The ADMA-Metformin Hypothesis: ...... Syndrome and Type 2 Diabetes.
@nl
prefLabel
The ADMA-Metformin Hypothesis: ...... c Syndrome and Type 2 Diabetes
@en
The ADMA-Metformin Hypothesis: ...... Syndrome and Type 2 Diabetes.
@nl
P2860
P921
P356
P1433
P1476
The ADMA-Metformin Hypothesis: ...... c Syndrome and Type 2 Diabetes
@en
P2093
William H Bestermann
P2860
P304
P356
10.1159/000332382
P577
2011-10-04T00:00:00Z